Antibody Therapeutics Patients First!

공지사항

``Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2`` is now indexed on PubMed.
  • 글쓴이 관리자
  • 작성일 2018-08-06 13:22:37
  • 조회수 5520

"Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody 

against vascular endothelial growth factor 2" is now indexed on PubMed.

 

 

PharmAbcine, a clinical stage immune-oncology company, today announced that "Preclinical pharmacokinetics, interspecies scaling, and 

pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2"

is now indexed on PubMed.

 

Link to your paper on PubMed: http://www.ncbi.nlm.nih.gov/pubmed/29563774

 

목록





이전글 Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited ...
다음글 `` Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, T...